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Abstract
Introduction
The term folate is used to describe natural folates found in 
foods, folic acid, folinic acid, and L-methylfolate. While 
folate is readily available in many foods and supplements, 
low levels of folate can occur due to poor dietary intake, 
genetic mutations which effect folate methylation, poor 
absorption in the gastrointestinal tract, excessive alcohol 
intake, and as a side effect to certain medications (Shelton, 
Manning, & Barrentine, 2013). L-methylfolate is the usable 
form of folate and is the only form that can cross the blood 
brain barrier. Folate is also necessary for the production of 
the neurotransmitters serotonin, norepinephrine, and 
dopamine, which are important for maintaining general 
and mental health. (DynaMed, 2016) 
The monoamine hypothesis of depression predicts that 
depression is the result of low levels of norepinephrine, 
dopamine and/or serotonin in the brain (McCance, K. L. & 
Huether, S. E., 2014). According to the Center for Disease 
Control and Prevention (CDC), more than 15 million adults 
have experienced depression within the last year. For those 
patients who seek treatment, many must try multiple 
medications to find one which is both effective and has few 
or tolerable side effects. Although the relationship between 
folate and depression was first recognized in the 1960’s, 
folate supplementation is not routinely recommended or 
prescribed for the treatment of depression. 
Research Questions
Discussion
Applicability to Clinical Practice
Literature Review
Methylfolate supplementation for the treatment of 
depression. 
Shelton, Manning, & Barrentine (2013) reported that 67.9% of 
study participants had some response to adjunctive treatment 
with L-methylfolate and 45.7% of participants achieved 
remission of depressive symptoms. Wade, Kindermann, Hou, 
and Thase (2014) showed that the addition of L-methylfolate is 
more effective than the addition of second-generation 
antipsychotics (SGAs) for the treatment of depression. The L-
methylfolate group was shown to have higher rates of 
adherence, lower depression-related costs, and lower general 
healthcare cost compared to patients taking SGA’s (p< 0.001).  
Numerous medications are available to treat depression, 
yet many patients do not achieve remission or recovery of 
their symptoms with traditional therapies alone. Folate 
supplementation has been shown to be beneficial in the 
treatment of depression when used in addition to 
traditional prescription therapy. A literature review was 
conducted to determine the effect of low folate levels on 
depression and if supplementation with either folic acid or 
L-methylfolate benefits this patient population. Key search 
terms including folate, folate deficiency, methylfolate, 
nutrition, and depression were used to perform searches of 
multiple databases and journals including PubMed, 
CINAHL, PsycInfo, and the American Journal of Psychiatry. 
Studies such as the one conducted by Loria-Kohen et al. 
(2013), demonstrated benefit in the use of folic acid 
supplementation in lowering depression scores. 
Researchers including Zajecka et al. (2016) have shown 
that due to its ability to cross the blood brain barrier, L-
methylfolate is the better option in the treatment of 
depression. Medical providers must determine the best 
treatment plan based on an individuals personalized needs 
while also considering the risks, benefits, testing options, 
and cost of treatment.
• In patients treated for depression using traditional antidepressants, 
should routine folate supplementation be considered as an 
adjunctive therapy for the reduction of depressive symptoms? 
• As an adjunct in treating depression, is folic acid or L-methylfolate 
more effective? 
The literature supports routine folate supplementation as an 
adjunctive treatment for depression. These studies also verify 
the relative safety of folate supplementation while showing the 
inefficiency of testing for folate deficiency. Based on the review 
of literature, L-methylfolate supplementation is superior to 
supplementation with folic acid in the treatment of depression 
when used in addition to traditional antidepressant 
medications. Also, whether supplementing with folic acid or L-
methylfolate, the best results were seen with high dose 
supplementation. Common limitations of current research 
include small sample sizes and the use of retrospective methods 
to gather data. Additional long-term studies are needed to 
confirm the benefits, assess for potential risks, and determine 
other contributing factors that may affect the decision whether 
or not to supplement depressed patients with L-methylfolate or 
folic acid.
Statement of the Problem
Both the Practice Guideline for the Treatment of Patients with Major 
Depressive Disorder (Gelenberg et al., 2010) and the American 
Psychiatric Association list folate as a complementary treatment 
which can be used in addition to traditional therapies. Neither of 
these guidelines provides clear recommendations for the type of 
supplement, dosage ranges, or monitoring that should be used when 
supplementing with folate in the treatment of depression.
References
Amazon (2017). BioTech Pharmacal - Folic Acid (5mg) - 100 Count. Retrieved from 
www.amazon.com
Amazon (2017). Methyl-Life Supplements Methylfolate 15mg - 90 Chewable Tablets. 
Retrieved from https://www.amazon.com
Bedson, E., Bell, D., Carr, D., Carter, B., Hughes, D., Jorgensen, A., … Williams, N. 
(2014). Folate augmentation of treatment - Evaluation for depression (folated): 
Randomised trial and economic evaluation. Health Technology Assessment, 
18(48), 1–159. https://doi.org/ 
Bottiglieri, T., Laundy, M., Crellin, R., Toone, B. K., Carney, M. W. P., & Reynolds, E. 
H. (2000). Homocysteine, folate, methylation, and monoamine metabolism in 
depression. J Neurol Neurosurg Psychiatry, 69, 228–232.
Centers for Disease Control and Prevention. (2016). National Center for Health 
Statistics – Depression. Retrieved October 23, 2016, from http://www.cdc.gov/
Fava, M., & Mischoulon, D. (2009). Folate in Depression: Efficacy, Safety, Differences 
inFormulations, and Clinical Issues. J Clin PsychiatryJ Clin Psychiatry, 7070(5), 12–
17.https://doi.org/10.4088/JCP.8157su1c.03
Gelenberg, A.J., Freeman, M. P., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., 
Trivedi, M. H., & Van Rhoads, R. S. (2010). Practice Guideline for the Treatment of 
Patients with Major Depressive Disorder. American Psychiatric Association. 
Retrieved from http://psychiatryonline.org
Loria-Kohen, V., Gómez-Candela, C., Palma-Milla, S., Amador-Sastre, B., Hernanz, A., 
& Bermejo, L. M. (2013). A pilot study of folic acid supplementation for improving 
homocysteine levels, cognitive and depressive status in eating disorders. Nutrición
Hospitalaria, 28(3), 807–15.
McCance, K. L. & Huether, S. E. (2014). Pathophysiology: the biologic basis for 
disease in adults and children (7th ed.). St. Louis, MO: Mosby. 
Miller, A. L. (2008). The Methylation, Neurotransmitter, and Antioxidant Connections 
Between Folate and Depression. Alternative Medicine ReviewAltern Med Rev, 
1313(3), 216–226.
Shelton, R. C., Manning, J. S., & Barrentine, L. W. (2013). Assessing Effects of L-
methylfolate in Depression Management: Results of a Real-World Patient 
Experience Trial. Prim Care Companion CNS Disord, 15(4), 1–9. 
Wade, R. L., Kindermann, S. L., Hou, Q., & Thase, M. E. (2014). Comparative 
assessment of adherence measures and resource use in SSRI/SNRI-treated patients 
with depression using second-generation antipsychotics or L-methylfolate as 
adjunctive therapy. Journal of Managed Care Pharmacy : JMCP, 20(1), 76–85. 
Zajecka, J. M., Fava, M., Shelton, R. C., Barrentine, L. W., Young, P., & Papakostas, G. 
I. (2016). Long-term efficacy, safety, and tolerability of l-methylfolate calcium 15 
mg as adjunctive therapy with selective serotonin reuptake inhibitors: A 12-month, 
open-label study following a placebo-controlled acute study. Journal of Clinical 
Psychiatry, 77(5), 654–660. 
Folate Deficiency 
Although many consider folate deficiency to be rare in the US, 
multiple studies have shown that testing for blood folate levels 
may be inconsistent and that depressive symptoms may occur 
without absolute deficiency. Bottiglieri et al. (2006) found that 
30.4% of depressed patients in their study had low levels of red 
cell folate (<150 μg/l). Compared with the healthy patients, the 
depressed group had a lower mean red cell folate level (t=3.12, 
p<0.01); even lower levels were observed in the depressed 
subgroup with high plasma homocysteine levels (t=4.73, 
p<0.01).
Folate methylation and neurotransmitters
Miller (2008) discussed that folate is an essential nutrient involved 
in synthesis of neurotransmitters such as dopamine and serotonin 
and thus is thought to play an important role in mood and 
cognition. Figure 1, published by Fava & Micshoulon (2009), 
provides a good illustration of the various types of folate and the 
methylation steps necessary for the formation of L-methylfolate. 
Folate intake and supplementation for the treatment of 
depression. 
Loria-Kohen et al. (2013) found a positive correlation between 
folic acid supplementation, decreased homocysteine levels, and 
decreased levels of depression. As total folate intake increased in 
the supplemented group, their Beck Depression Inventory scores 
decrease (r= -0.581, p < 0.05). In contrast, The FolATED study 
showed that patients treated with 5 mg of folic acid provided no 
clinical benefit in the treatment of depression; adjusted difference 
between patients treated with folic acid and those with placebo at 
25 weeks was insignificant at 1.27 (95% CI; p = 0.27). 
• Without clear guidelines, the decision of whether or not to 
recommend folate supplementation is a provider decision 
based on each unique patient presentation. 
• Providers must consider the potential causes of low folate 
levels including poor diet, genetic mutations which affect 
folate methylation, conditions which cause poor absorption in 
the gastrointestinal tract, excessive alcohol intake, and 
medication side effects.
• Cost and applicability of testing
• Cost varies widely based on insurance and lab.
• If only those patients with a clear folate deficiency are 
treated, some patients who may benefit from folate 
supplementation would not be included. 
• Financial cost of supplementation
• Folic acid 5 mg
• $11.95 for a 100-day supply. 
• L-methylfolate 15 mg
• $140 for a 30-day supply of Deplin
• $174 for a 90-day supply with Rx card
• $79.00 for a 90-day supply of generic 
